39th Annual Midwinter Retina Symposium: A Medley of Retina with a Twist of Uveitis
In this conference, we will focus on how shifting demographics dictate increasing prevalence of age-related eye disease among the US population. It is not unusual for primary eyecare providers (ophthalmologists and optometrists) to treat patients with multiple age-related eye diseases such as cataracts with age-related macular degeneration; cataracts with diabetic retinopathy; cataracts with uveitis, etc. These intersecting diagnoses complicate management decisions. It is challenging to stay current with the state-of-the-art, especially when much of the research and updates appear in subspecialty literature. Given the sparsity of specialists, it is helpful to educate the primary eyecare providers about diagnosis, management, or understanding when and how quickly to refer necessary cases.
Key Words: Uveitis, retinal diseases, patient care, referral and consultation
This educational activity is aimed at practicing ophthalmologists, subspecialty ophthalmologists, fellows, residents, optometrists, medical students, graduate students, postdoctoral fellows, vision scientists and retina photographers.
- Discuss the use of systemic and local treatments in the management of chronic uveitis, novel treatments of uveitis, and the use of imaging and other modalities to follow patients with chronic uveitis.
- Discuss the manifestations of pathologic myopia, including myopic traction maculopathy.
- Review current and novel treatment in age-related macular degeneration.
- Review clinical features suggestive for intraocular lymphoma.
- Discuss recent advances in genetics-based clinical trials for CXLRS.
- Describe considerations and factors when advising patients about visually significant vitreous opacities.
8:00–8:05 a.m. Introduction and Welcome Baseer U. Ahmad, MD
8:05–8:25 a.m. New Treatment Options for AMD Judy E. Kim, MD
8:25–8:45 a.m. An Update on Congenital X-linked Retinoschisis Clinton C. Warren, MD
8:45–9:05 a.m. Visually Significant Vitreous Opacities: Thoughts & Management Baseer U. Ahmad, MD
9:05–9:10 a.m. Gary W. Abrams Lectureship Introduction Thomas B. Connor, Jr., MD
9:10–9:40 a.m. 5th Annual Gary W. Abrams Endowed Lecture: Treatment of Uveitis in 2022 - When to treat, How to Treat and How to Follow to Maximize Outcomes Sunil Srivastava, MD
9:40–9:55 a.m. Break
9:55–10:25 a.m. I Can Now Breathe Easier: A Case of Unilateral Panuveitis After a COVID Infection Joon-Bom Kim, MD
10:25–10:45 a.m. Helpful Hints for Diagnosing Intraocular Lymphoma William J. Wirostko, MD
10:45–11:15 a.m. The Upcoming Epidemic of Vision Loss Due to Pathologic Myopia Eileen Hwang, MD, PhD
11:15–11:35 a.m. Mimics of Age-Related Macular Degeneration Surgery David V. Weinberg, MD
11:35-11:55 a.m. “What the?!” – A Strategic Approach to Retinal Degenerations and Dystrophies Thomas B. Connor, Jr., MD
11:55 a.m.–12:25 p.m. Case Presentation and Panel Discussion
12:25–12:30 p.m. Closing Remarks and A
Baseer U. Ahmad, MD
Assistant Professor of Ophthalmology & Visual Sciences
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest resolution process and resolved.
|Sunil Srivastava, MD||Bausch||Consultant||Consultant fees|
|Regeneron||Consultant, Researcher||Research funding|
|Judy Kim, MD||Alimera Science||Advisory Committee||Honorarium|
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 4.25 hours of participation for continuing education for allied health professionals.
- 4.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.25 Hours of ParticipationHours of Participation credit.
Please note: Google Chrome and Mozilla Firefox are the preferred browsers.